Noom Med vs Oak Longevity: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent research·How we rank →

Oak Longevity beats Noom Med overall, scoring 7.5/10 vs 7.4/10. Noom Med is more affordable at $99/mo vs $130/mo. Choose Noom Med for users who want a tiered entry into glp-1 care — from $99/mo . Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.

A side-by-side comparison of Noom Med and Oak Longevity covering pricing, scores, medication types, insurance, and more to help you decide.

Noom Med

#28 of 49

7.4/10

Noom restructured Noom Med in 2026 into 3 tiers: $69/mo branded telehealth (med out-of-pocket), $99-149/mo Microdose GLP-1Rx (low-dose + biomarker monitoring), and the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.

Visit Noom Med

Higher Rated

Oak Longevity

#26 of 49

7.5/10

Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing — patients pay each month manually rather than auto-renew.

Visit Oak Longevity

Feature	Noom Med	Oak Longevity
Our Score	7.4/10	7.5/10
Starting Price	$99/mo	$130/mo
Medication Type	Both	Both
Insurance Accepted	Yes	No
Best For	Users who want a tiered entry into GLP-1 care — from $99/mo Microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program	Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin)
Ranking	#28	#26

Pros & Cons Compared

Noom Med

Pros

+Tiered 2026 entry — $69/mo branded telehealth tier lets users start with just medication access and the coaching app
+New Microdose GLP-1Rx program ($99-149/mo) — low-dose GLP-1 + biomarker monitoring for sensitive users
+Insurance accepted for qualifying plans — can significantly reduce out-of-pocket costs on brand-name meds
+Industry-leading behavioral coaching app with years of psychology-based weight loss methodology

Cons

−Tiered pricing creates confusion — $69, $99-149, or $149-349 depending on tier
−Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
−Medication costs on the $69 tier are out-of-pocket — the low tier price is just the platform
−App coaching still requires real engagement — skip-prone users waste the behavioral value

Oak Longevity

Pros

+$130/mo for compounded semaglutide is among the cheapest entries on the market — Sprout Health ($99) is lower, but Oak undercuts most mid-tier platforms
+Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
+No-subscription model — patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
+Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
+Money-back guarantee if not approved by physician — useful safety net for borderline-eligibility patients
+Free shipping and free health coaching included in every program

Cons

−Brand-name pricing ($1,200-$1,500/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo, LillyDirect Zepbound $299/mo. Never buy brand-name through Oak
−No published lab panels, no specialty (obesity medicine) physicians disclosed — clinical depth is shallow
−'Up to 50% cheaper than competitors' marketing claim is unverified and inconsistent — depends on which competitor and which medication tier
−'Longevity' framing pushes users toward add-on products (NAD+, Sermorelin, Tesamorelin) that have limited clinical evidence for weight loss specifically
−Newer brand without disclosed company history, founding date, or executive team on landing pages
−Three-month plans are billed upfront — pricing transparency is good, but commit-up-front is a friction point for users testing the platform

Our Verdict

Oak Longevity edges out Noom Med with a score of 7.5/10 vs 7.4/10. If budget is your priority, Noom Med starts at $99/mo compared to Oak Longevity's $130/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Noom Med if you want: users who want a tiered entry into glp-1 care — from $99/mo microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Noom Med nor Oak Longevity feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review